Inhibitory effects of 405nm irradiation on Chlamydia trachomatis growth and characterization of the ensuing inflammatory response in HeLa cells

BMC Microbiology

Volumn 12, Issue , 2012, Pages

  Wasson, Cassandra J ^a,e   Zourelias, Jessica L ^a,f   Aardsma, Nathan A ^b,g   Eells, Janis T ^c   Ganger, Mike T ^a   Schober, Justine M ^d   Skwor, Troy A ^a,h  

^a GANNON UNIVERSITY   (United States)

^b LAKE ERIE COLLEGE OF OSTEOPATHIC MEDICINE   (United States)

^c UNIVERSITY OF WISCONSIN MILWAUKEE   (United States)

^d HAMOT MEDICAL CENTER   (United States)

^e MIDWESTERN UNIVERSITY   (United States)

^f UNIVERSITY AT BUFFALO   (United States)

^g UNIVERSITY OF ILLINOIS AT CHICAGO   (United States)

^h Starr Science Building   (United States)

Author keywords

405nm; CCL2; Chlamydia trachomatis; IL 6; Phototherapy

Indexed keywords

GLYCERALDEHYDE 3 PHOSPHATE DEHYDROGENASE; INTERLEUKIN 6; MONOCYTE CHEMOTACTIC PROTEIN 1; CCL2 PROTEIN, HUMAN;

ANTIBACTERIAL ACTIVITY; ARTICLE; BACTERIAL GROWTH; CELL LEVEL; CHLAMYDIA TRACHOMATIS; CONCENTRATION RESPONSE; CONTROLLED STUDY; CYTOKINE PRODUCTION; FEMALE; GROWTH INHIBITION; HELA CELL; HUMAN; HUMAN CELL; IN VITRO STUDY; INFLAMMATION; IRRADIATION; LIGHT EMITTING DIODE; MOLECULAR MODEL; NONHUMAN; QUANTITATIVE ANALYSIS; RADIATION RESPONSE; REAL TIME POLYMERASE CHAIN REACTION; SUPERNATANT; EPITHELIUM CELL; GROWTH, DEVELOPMENT AND AGING; IMMUNOLOGY; LIGHT; MICROBIOLOGY; RADIATION EXPOSURE; SECRETION (PROCESS);

BACTERIA (MICROORGANISMS); CHLAMYDIA TRACHOMATIS;

CHEMOKINE CCL2; CHLAMYDIA TRACHOMATIS; EPITHELIAL CELLS; HELA CELLS; HUMANS; INTERLEUKIN-6; LIGHT;

EID: 84864912845     PISSN: None     EISSN: 14712180     Source Type: Journal    
DOI: 10.1186/1471-2180-12-176     Document Type: Article

References (61)

1. Global data on visual impairment in the year 2002. Resnikoff S, Pascolini D, Etya'ale D, Kocur I, Pararajasegaram R, Pokharel GP, Mariotti SP, Bull World Health Organ 2004 82 11 844 851 15640920
2. Multiple Chlamydiaceae species in trachoma: implications for disease pathogenesis and control. Dean D, Kandel RP, Adhikari HK, Hessel T, PLoS Med 2008 5 1 14 10.1371/journal.pmed.0050014 18177205
3. Global epidemiology of sexually transmitted diseases. Gerbase AC, Rowley JT, Mertens TE, Lancet 1998 351 Suppl 3 2 4 9652711
4. Chlamydia trachomatis Sexually Transmitted Diseases. Dean D, Pathology of Infectious Diseases. Volume 1 Appleton and Lange Publishers, Stamford, CT, Conner DH, Schwartz DA, Chandler FW, 1997 473 490
5. Immunology of Chlamydia infection: implications for a Chlamydia trachomatis vaccine. Brunham RC, Rey-Ladino J, Nat Rev Immunol 2005 5 2 149 161 10.1038/nri1551 15688042
6. Clinical practice. Genital chlamydial infections. Peipert JF, N Engl J Med 2003 349 25 2424 2430 10.1056/NEJMcp030542 14681509
7. Persistent chlamydiae: from cell culture to a paradigm for chlamydial pathogenesis. Beatty WL, Morrison RP, Byrne GI, Microbiol Rev 1994 58 4 686 699 7854252
8. Secretion of proinflammatory cytokines by epithelial cells in response to Chlamydia infection suggests a central role for epithelial cells in chlamydial pathogenesis. Rasmussen SJ, Eckmann L, Quayle AJ, Shen L, Zhang YX, Anderson DJ, Fierer J, Stephens RS, Kagnoff MF, J Clin Invest 1997 99 1 77 87 10.1172/JCI119136 9011579
9. Chlamydia trachomatis infection of epithelial cells induces the activation of caspase-1 and release of mature IL-18. Lu H, Shen C, Brunham RC, J Immunol 2000 165 3 1463 1469 10903751
10. The reprogrammed host: Chlamydia trachomatis-induced up-regulation of glycoprotein 130 cytokines, transcription factors, and antiapoptotic genes. Hess S, Rheinheimer C, Tidow F, Bartling G, Kaps C, Lauber J, Buer J, Klos A, Arthritis Rheum 2001 44 10 2392 2401 10.1002/1529-0131(200110)44:10<2392:: AID-ART404>3.0.CO;2-I 11665982
11. Local host response to chlamydial urethral infection in male guinea pigs. Wang Y, Nagarajan U, Hennings L, Bowlin AK, Rank RG, Infect Immun 2010 78 4 1670 1681 10.1128/IAI.01339-09 20123720
12. Protective or pathogenic immune response to genital chlamydial infection in women-a possible role of cytokine secretion profile of cervical mucosal cells. Agrawal T, Gupta R, Dutta R, Srivastava P, Bhengraj AR, Salhan S, Mittal A, Clin Immunol 2009 130 3 347 354 10.1016/j.clim.2008.10.004 19019735
13. Role of secreted conjunctival mucosal cytokine and chemokine proteins in different stages of trachomatous disease. Skwor TA, Atik B, Kandel RP, Adhikari HK, Sharma B, Dean D, PLoS Negl Trop Dis 2008 2 7 264 10.1371/journal.pntd. 0000264 18628987
14. Toll-like receptor-2, but not Toll-like receptor-4, is essential for development of oviduct pathology in chlamydial genital tract infection. Darville T, O'Neill JM, Andrews CW, Nagarajan UM, Stahl L, Ojcius DM, J Immunol 2003 171 11 6187 6197 14634135
15. Randomised controlled trial of single-dose azithromycin in treatment of trachoma. Bailey RL, Arullendran P, Whittle HC, Mabey DC, Lancet 1993 342 8869 453 456 10.1016/0140-6736(93)91591-9 8102427
16. Re-emergence of Chlamydia trachomatis infection after mass antibiotic treatment of a trachoma-endemic Gambian community: a longitudinal study. Burton MJ, Holland MJ, Makalo P, Aryee EA, Alexander ND, Sillah A, Faal H, West SK, Foster A, Johnson GJ, et al. Lancet 2005 365 9467 1321 1328 10.1016/S0140- 6736(05)61029-X 15823382
17. Infection with Chlamydia trachomatis after mass treatment of a trachoma hyperendemic community in Tanzania: a longitudinal study. West SK, Munoz B, Mkocha H, Holland MJ, Aguirre A, Solomon AW, Foster A, Bailey RL, Mabey DC, Lancet 2005 366 9493 1296 1300 10.1016/S0140-6736(05)67529-0 16214600
18. Feasibility of eliminating ocular Chlamydia trachomatis with repeat mass antibiotic treatments. Melese M, Chidambaram JD, Alemayehu W, Lee DC, Yi EH, Cevallos V, Zhou Z, Donnellan C, Saidel M, Whitcher JP, et al. JAMA 2004 292 6 721 725 10.1001/jama.292.6.721 15304470
19. Impact of annual targeted treatment on infectious trachoma and susceptibility to reinfection. Atik B, Thanh TT, Luong VQ, Lagree S, Dean D, Jama 2006 296 12 1488 1497 10.1001/jama.296.12.1488 17003397
20. Risk factors for recurrence of postoperative trichiasis: implications for trachoma blindness prevention. Zhang H, Kandel RP, Sharma B, Dean D, Arch Ophthalmol 2004 122 4 511 516 10.1001/archopht.122.4.511 15078668
21. Risk factors for postsurgical trichiasis recurrence in a trachoma-endemic area. West ES, Mkocha H, Munoz B, Mabey D, Foster A, Bailey R, West SK, Invest Ophthalmol Vis Sci 2005 46 2 447 453 10.1167/iovs.04-0600 15671268
22. The unexpected impact of a Chlamydia trachomatis infection control program on susceptibility to reinfection. Brunham RC, Pourbohloul B, Mak S, White R, Rekart ML, J Infect Dis 2005 192 10 1836 1844 10.1086/497341 16235186
23. Biphasic dose response in low level light therapy. Huang YY, Chen AC, Carroll JD, Hamblin MR, Dose-Response 2009 7 4 358 383 10.2203/dose-response.09- 027.Hamblin 20011653
24. Inactivation of bacterial pathogens following exposure to light from a 405-nanometer light-emitting diode array. Maclean M, MacGregor SJ, Anderson JG, Woolsey G, Appl Environ Microbiol 2009 75 7 1932 1937 10.1128/AEM.01892-08 19201962
25. Helicobacter pylori accumulates photoactive porphyrins and is killed by visible light. Hamblin MR, Viveiros J, Yang C, Ahmadi A, Ganz RA, Tolkoff MJ, Antimicrob Agents Chemother 2005 49 7 2822 2827 10.1128/AAC.49.7.2822-2827.2005 15980355
26. In vitro bactericidal effects of 405-nm and 470-nm blue light. Guffey JS, Wilborn J, Photomed Laser Surg 2006 24 6 684 688 10.1089/pho.2006.24.684 17199466
27. Photoinactivation of Acinetobacter baumannii and Escherichia coli B by a cationic hydrophilic porphyrin at various light wavelengths. Nitzan Y, Ashkenazi H, Curr Microbiol 2001 42 6 408 414 10.1007/s002840010238 11381332
28. Anti-microbial photodynamic therapy: useful in the future? Maisch T, Lasers Med Sci 2007 22 2 83 91 10.1007/s10103-006-0409-7 17120167
29. Chemokine and chemokine receptor dynamics during genital chlamydial infection. Belay T, Eko FO, Ananaba GA, Bowers S, Moore T, Lyn D, Igietseme JU, Infect Immun 2002 70 2 844 850 10.1128/IAI.70.2.844-850.2002 11796619
30. Effect of Th1/Th2 cytokine pretreatment on RSV-induced gene expression in airway epithelial cells. Yamada Y, Matsumoto K, Hashimoto N, Saikusa M, Homma T, Yoshihara S, Saito H, Int Arch Allergy Immunol 2011 154 3 185 194 10.1159/000321105 20861640
31. Alteration of Chlamydia trachomatis biologic behavior in synovial membranes. Suppression of surface antigen production in reactive arthritis and Reiter's syndrome. Nanagara R, Li F, Beutler A, Hudson A, Schumacher HR, Arthritis Rheum 1995 38 10 1410 1417 10.1002/art.1780381008 7575691
32. Detection of Chlamydia trachomatis in fallopian tube tissue in women with postinfectious tubal infertility. Patton DL, Askienazy-Elbhar M, Henry-Suchet J, Campbell LA, Cappuccio A, Tannous W, Wang SP, Kuo CC, Am J Obstet Gynecol 1994 171 1 95 101 8030740
33. Repeated Chlamydia trachomatis genital infections in adolescent women. Batteiger BE, Tu W, Ofner S, Van Der Pol B, Stothard DR, Orr DP, Katz BP, Fortenberry JD, J Infect Dis 2010 201 1 42 51 10.1086/648734 19929379
34. Effect of expedited treatment of sex partners on recurrent or persistent gonorrhea or chlamydial infection. Golden MR, Whittington WL, Handsfield HH, Hughes JP, Stamm WE, Hogben M, Clark A, Malinski C, Helmers JR, Thomas KK, et al. N Engl J Med 2005 352 7 676 685 10.1056/NEJMoa041681 15716561
35. The effective treatment of acne vulgaris by a high-intensity, narrow band 405-420nm light source. Elman M, Slatkine M, Harth Y, J Cosmet Laser Ther 2003 5 2 111 117 10.1080/14764170310001276 12850803
36. Treatment of Helicobacter pylori infection with intra-gastric violet light phototherapy: a pilot clinical trial. Lembo AJ, Ganz RA, Sheth S, Cave D, Kelly C, Levin P, Kazlas PT, Baldwin PC, Lindmark WR, McGrath JR, et al. Lasers Surg Med 2009 41 5 337 344 10.1002/lsm.20770 19533762
37. Inactivation of Campylobacter jejuni by exposure to high-intensity 405-nm visible light. Murdoch LE, Maclean M, MacGregor SJ, Anderson JG, Foodborne Pathog Dis 2010 7 10 1211 1216 10.1089/fpd.2010.0561 20590423
38. The role of oxygen in the visible-light inactivation of Staphylococcus aureus. Maclean M, Macgregor SJ, Anderson JG, Woolsey GA, J Photochem Photobiol B 2008 92 3 180 184 10.1016/j.jphotobiol.2008.06.006 18657991
39. Eradication of Propionibacterium acnes by its endogenic porphyrins after illumination with high intensity blue light. Ashkenazi H, Malik Z, Harth Y, Nitzan Y, FEMS Immunol Med Microbiol 2003 35 1 17 24 10.1111/j.1574-695X.2003. tb00644.x 12589953
40. Production of reactive oxygen species is turned on and rapidly shut down in epithelial cells infected with Chlamydia trachomatis. Boncompain G, Schneider B, Delevoye C, Kellermann O, Dautry-Varsat A, Subtil A, Infect Immun 2010 78 1 80 87 10.1128/IAI.00725-09 19858301
41. Cleavage of host keratin 8 by a Chlamydia-secreted protease. Dong F, Su H, Huang Y, Zhong Y, Zhong G, Infect Immun 2004 72 7 3863 3868 10.1128/IAI.72.7.3863-3868.2004 15213128
42. Identification of a chlamydial protease-like activity factor responsible for the degradation of host transcription factors. Zhong G, Fan P, Ji H, Dong F, Huang Y, J Exp Med 2001 193 8 935 942 10.1084/jem.193.8.935 11304554
43. The host adherens junction molecule nectin-1 is degraded by chlamydial protease-like activity factor (CPAF) in Chlamydia trachomatis-infected genital epithelial cells. Sun J, Schoborg RV, Microbes Infect 2009 11 1 12 19 10.1016/j.micinf.2008.10.001 18983929
44. The secreted protease factor CPAF is responsible for degrading pro-apoptotic BH3-only proteins in Chlamydia trachomatis-infected cells. Pirbhai M, Dong F, Zhong Y, Pan KZ, Zhong G, J Biol Chem 2006 281 42 31495 31501 10.1074/jbc.M602796200 16940052
45. Serum concentrations of interleukin-2R (IL-2R), IL-6, IL-8, and tumor necrosis factor alpha in patients with ectopic pregnancy. Soriano D, Hugol D, Quang NT, Darai E, Fertil Steril 2003 79 4 975 980 10.1016/S0015-0282(02)04853-7 12749440
46. The influence of persistent pathogens on circulating levels of inflammatory markers: a cross-sectional analysis from the Multi-Ethnic Study of Atherosclerosis. Nazmi A, Diez-Roux AV, Jenny NS, Tsai MY, Szklo M, Aiello AE, BMC Publ Health 2010 10 706 10.1186/1471-2458-10-706
47. Repeated Chlamydia trachomatis infection of Macaca nemestrina fallopian tubes produces a Th1-like cytokine response associated with fibrosis and scarring. Van Voorhis WC, Barrett LK, Sweeney YT, Kuo CC, Patton DL, Infect Immun 1997 65 6 2175 2182 9169748
48. Silencing or permanent activation: host-cell responses in models of persistent Chlamydia pneumoniae infection. Peters J, Hess S, Endlich K, Thalmann J, Holzberg D, Kracht M, Schaefer M, Bartling G, Klos A, Cell Microbiol 2005 7 8 1099 1108 10.1111/j.1462-5822.2005.00534.x 16008577
49. Altered protein secretion of Chlamydia trachomatis in persistently infected human endocervical epithelial cells. Wang J, Frohlich KJ, Buckner L, Quayle AJ, Luo M, Feng X, Beatty W, Hua Z, Rao X, Lewis ME, et al. Microbiology 2011 157 10 2759 2771 10.1099/mic.0.044917-0 21737500
50. A chlamydial type III translocated protein is tyrosine-phosphorylated at the site of entry and associated with recruitment of actin. Clifton DR, Fields KA, Grieshaber SS, Dooley CA, Fischer ER, Mead DJ, Carabeo RA, Hackstadt T, Proc Natl Acad Sci U S A 2004 101 27 10166 10171 10.1073/pnas.0402829101 15199184
51. Localization of Chlamydia trachomatis hypothetical protein CT311 in host cell cytoplasm. Lei L, Qi M, Budrys N, Schenken R, Zhong G, Microb Pathog 2011 51 3 101 109 10.1016/j.micpath.2011.05.002 21605656
52. Chlamydia trachomatis secretion of an immunodominant hypothetical protein (CT795) into host cell cytoplasm. Qi M, Lei L, Gong S, Liu Q, DeLisa MP, Zhong G, J Bacteriol 2011 193 10 2498 2509 10.1128/JB.01301-10 21441519
53. UVA-induced autocrine stimulation of fibroblast-derived-collagenase by IL-6: a possible mechanism in dermal photodamage? Wlaschek M, Bolsen K, Herrmann G, Schwarz A, Wilmroth F, Heinrich PC, Goerz G, Scharffetter-Kochanek K, J Invest Dermatol 1993 101 2 164 168 10.1111/1523-1747.ep12363644 7688402
54. UVA-induced autocrine stimulation of fibroblast-derived collagenase/MMP-1 by interrelated loops of interleukin-1 and interleukin-6. Wlaschek M, Heinen G, Poswig A, Schwarz A, Krieg T, Scharffetter-Kochanek K, Photochem Photobiol 1994 59 5 550 556 10.1111/j.1751-1097.1994.tb02982.x 8041811
55. Granulocyte/macrophage colony-stimulating factor is an intrinsic keratinocyte-derived growth factor for human melanocytes in UVA-induced melanosis. Imokawa G, Yada Y, Kimura M, Morisaki N, Biochem J 1996 313 Pt 2 625 631 8573102
56. Persistent Chlamydia trachomatis infections resist apoptotic stimuli. Dean D, Powers VC, Infect Immun 2001 69 4 2442 2447 10.1128/IAI.69.4.2442-2447. 2001 11254605
57. Hypervirulent Chlamydia trachomatis clinical strain is a recombinant between lymphogranuloma venereum (L2) and D lineages. Somboonna N, Wan R, Ojcius DM, Pettengill MA, Joseph SJ, Chang A, Hsu R, Read TD, Dean D, MBio 2011 2 3 00045 11 21540364
58. Near-infrared light via light-emitting diode treatment is therapeutic against rotenone- and 1-methyl-4-phenylpyridinium ion-induced neurotoxicity. Liang HL, Whelan HT, Eells JT, Wong-Riley MT, Neuroscience 2008 153 4 963 974 10.1016/j.neuroscience.2008.03.042 18440709
59. Granulocyte-macrophage colony-stimulating factor enhancer activation requires cooperation between NFAT and AP-1 elements and is associated with extensive nucleosome reorganization. Johnson BV, Bert AG, Ryan GR, Condina A, Cockerill PN, Mol Cell Biol 2004 24 18 7914 7930 10.1128/MCB.24.18.7914-7930. 2004 15340054
60. Detection by broad-range real-time PCR assay of Chlamydia species infecting human and animals. Goldschmidt P, Rostane H, Sow M, Goepogui A, Batellier L, Chaumeil C, Br J Ophthalmol 2006 90 11 1425 1429 10.1136/bjo.2006.096420 16899531
61. Sokal R, Rohlf F, Biometry W.H. Freeman Company, New York 3 1995